➖➖➖➖➖➖➖➖➖➖➖➖ New Drugs: 2017 - Till August ➖➖➖➖➖➖➖➖➖➖➖➖ 1. Avelumab: Anti PD1 (Programmed Death ligand 1 Ab approved for metastatic Merkel cell carcinoma. 2. Dupilumab: Anti IL 4 receptor alpha antibody approved for treatment of atopic dermatitis. 3. Brodalumab: Anti IL 17 A receptor Ab approved for treatment of plaque psoriasis. 4. Plecanatide: Guanylate cyclase c stimulator approved for treatment of chronic idiopathic constipation. It increases cyc GMP, which stimulates CTFR ( Cystic Fibrosis Transmembrane Regulator), which increases Cl ion secretion in to gut. 5. Naldenedine: Opioid antagonist approved for treatment of opioid induced constipation. 6. Telotristat: Tryptophan hydroxylase inibitor approved for treatment of carcinoid syndrome. It inhibits serotonin synthesis. 7. Midostaurin: Multikinase inhibitor approved for treatment of • AML: Along with TOC (Cytarabine + Daunorobicin) in FLT3 mutation positive cases. • Aggressive systemic mastocytosis • Syst...